Coya Therapeutics, Inc. Common Stock
COYA
Closed
$5.26
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Houston, Texas and currently employs 8 full-time employees. The company went IPO on 2022-12-29.
Country
US
CEO
Dr. Arun Swaminathan
IPO date
2022
Employees
8
ISIN
US22407B1089
Website
Key stats
Open
$5.33
Volume
264.29K
Market cap
$123.38M
Prev. close
$5.26
Impl / hst vl
-
Open interest
$0.00
$4.99
Day’s Range
$5.63
$3.71
52W Range
$6.21
Valuation
50
Valuation score
Fairly Valued
P/E
-
P/S
15.84
P/B
2.57
Current ratio
15.02
Debt / Equity
-1.04
ROE
-57.26%
Gross margin
-
Income growth
26.25%
FCF growth
516.47
Analysts estimates
Consensus rating
Buy
The average rating from top 8 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$16.07
The top 8 analysts forecasts that 12-month price may increase by 205.42%, with a low of $14.14 and a high of $18.90
$14.14
Low
$16.07
Avg
$18.90
High
Current price
Earnings
Q1 ‘26 revenue
$251.20K
Q1 ‘26 net income
-$7.21M
Revenue
Net income
Previous EPS
-$0.32
Estimate EPS
-$0.35
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply